Impact of resolvin mediators in the immunopathology of diabetes and wound healing

References

• Tsalamandris S, Antonopoulos AS, Oikonomou E, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14(1):50–59.
   PubMed Web of Science ®Google Scholar
• Hellmann J, Tang Y, Spite M, et al. Proresolving lipid mediators and diabetic wound healing. Curr Opin Endocrinol Diabetes Obes. 2012;19(2):104–108.
   PubMedGoogle Scholar
• Freire MO, Dalli J, Serhan CN, et al. Neutrophil resolvin E1 receptor expression and function in type 2 diabetes. J Immunol. 2017;198(2):718–728.
   PubMed Web of Science ®Google Scholar
• Pal A, Al‐Shaer AE, Guesdon W, et al. Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner. Faseb J. 2020;34(8):10640–10656.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang MJ, Hellmann J, et al. Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes. 2013;62(2):618–627.
   PubMed Web of Science ®Google Scholar
• Sima C, Paster B, Van Dyke TE, et al. Function of pro-resolving lipid mediator resolvin E1 in type 2 diabetes. Crit Rev Immunol. 2018;38(5):343–365.
   PubMed Web of Science ®Google Scholar
• Spite M, Clària J, Serhan C, et al. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19(1):21–36.
   PubMed Web of Science ®Google Scholar
• Thankam FG, Ayoub JG, Ahmed MMR, et al. Association of hypoxia and mitochondrial damage associated molecular patterns in the pathogenesis of vein graft failure: a pilot study. Transl Res. 2021;229:38–52.
   PubMed Web of Science ®Google Scholar
• Satish M, Agrawal DK. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition. Transl Res. 2020;215:75–85.
   PubMed Web of Science ®Google Scholar
• Satish M, Gunasekar P, Agrawal DK. Pro-inflammatory and pro-resolving mechanisms in the immunopathology of arteriovenous fistula maturation. Expert Rev Cardiovasc Ther. 2019;17(5):369–376.
   Web of Science ®Google Scholar
• Satish M, Agrawal DK. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases. Expert Rev Cardiovasc Ther. 2019;17(3):177–184.
   Web of Science ®Google Scholar
• Wallace HA, Basehore BM, Zito PM. Wound healing phases. StatPearls. 2020;29.
   Google Scholar
• Patel S, Srivastava S, Singh MR, et al. Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacothe. 2019;112:108615.
   Web of Science ®Google Scholar
• Pradhan L, Nabzdyk C, Andersen ND, et al. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med. 2009;11. DOI:10.1017/S1462399409000945.
   PubMed Web of Science ®Google Scholar
• Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012;32:203–227.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan JA, Sharma-Walia N. Lipoxins: nature’s way to resolve inflammation. J Inflamm Res. 2015;8:181–192.
   PubMed Web of Science ®Google Scholar
• Fu T, Mohan M, Brennan EP, et al. Therapeutic potential of lipoxin A4 in chronic inflammation: focus on cardiometabolic disease. ACS Pharmacol Transl Sci. 2020;3,1:43–55.
   Google Scholar
• Hellmann J, Tang Y, Kosuri M, et al. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. Faseb J. 2011;25(7):2399–2407.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657–2669.
   PubMed Web of Science ®Google Scholar
• Arita M, Ohira T, Sun YP, et al. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J immunol. 1950;178(6):2007.
   Google Scholar
• Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012;61(11):2937–2947.
   PubMed Web of Science ®Google Scholar
• Hoke GD, Ramos C, Hoke NN, et al. Atypical diabetic foot ulcer keratinocyte protein signaling correlates with impaired wound healing. J Diabetes Res. 2016;2016:1586927.
   PubMed Web of Science ®Google Scholar
• Jere SW, Houreld NN, Abrahamse H, et al. Role of the PI3K/AKT (mTOR and GSK3β) signalling pathway and photobiomodulation in diabetic wound healing. Cytokine Growth Factor Rev. 2019;50:52–59.
   PubMed Web of Science ®Google Scholar
• Zubair M, Ahmad J. Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review. Rev Endocr Metab Disord. 2019;20(2):207–217.
   PubMed Web of Science ®Google Scholar
• Li C, Wu X, Liu S, et al. Role of resolvins in the inflammatory resolution of neurological diseases. Front Pharmacol. 2020;11:612.
   PubMed Web of Science ®Google Scholar
• Pakyari M, Farrokhi A, Maharlooei MK, et al. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care. 2013;2(5):215–224.
   Google Scholar
• Al-Mulla F, Leibovich SJ, Francis IM, et al. Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol Biosyst. 2011;7(11):3006–3020.
   PubMedGoogle Scholar
• Khaled M, Shibani N-A, Labban N, et al. Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts. J Periodontol. 2013;84(12):1838–1846.
   PubMed Web of Science ®Google Scholar
• El Gazaerly H, Elbardisey DM, Eltokhy HM, et al. Effect of transforming growth factor Beta 1 on wound healing in induced diabetic rats. Int J Health Sci (Qassim). 2013;7(2):160–172.
   PubMedGoogle Scholar
• Luo B, Han F, Xu K, et al. Resolvin D1 programs inflammation resolution by increasing TGF- expression induced by dying cell clearance in experimental autoimmune neuritis. J Neurosci. 2016;36(37):9590–9603.
   Web of Science ®Google Scholar
• Zheng S, Wang Q, D’Souza V, et al. Resolvin D1 stimulates epithelial wound repair and inhibits TGF-β-induced EMT whilst reducing fibroproliferation and collagen production. Lab Invest. 2018;98(1):130–140.
   PubMed Web of Science ®Google Scholar
• Shu Y, Liu Y, Li X, et al. Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EndMT through increasing the expression of smad7 and is closely related to oxidative stress. Biomol Ther (Seoul). 2016;24(2):132–139.
   PubMed Web of Science ®Google Scholar
• Qu X, Zhang X, Yao J, et al. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol. 2012;228(4):506–519.
   PubMed Web of Science ®Google Scholar
• Lee H-N, Kundu JK, Cha YN, et al. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression. J Cell Sci. 2013;126(Pt 17):4037–4047.
   Web of Science ®Google Scholar
• Kourtzelis I, Hajishengallis G, Chavakis T, et al. Phagocytosis of apoptotic cells in resolution of inflammation. Front Immunol. 2020;11(553):31.
   PubMedGoogle Scholar
• Ortega-Gómez A, Perretti M, Soehnlein O, et al. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013;5(5):661–674.
   Web of Science ®Google Scholar
• Serhan CN, Chiang N, Dalli J, et al. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2014;7(2):a016311. 30.
   PubMed Web of Science ®Google Scholar
• Pirault J, Magnus B. Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease. Front Pharmacol. 2018;9:1273.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy S, Recchiuti A, Chiang N, et al. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol. 2012;180(5):2018–2027.
   PubMed Web of Science ®Google Scholar
• Sima C, Montero E, Nguyen D, et al. ERV1 overexpression in myeloid cells protects against high fat diet induced obesity and glucose intolerance. Sci Rep. 2017;7(1):12848.
   PubMedGoogle Scholar
• Oehler B, Mohammadi M, Perpina Viciano C, et al. Peripheral interaction of resolvin D1 and E1 with opioid receptor antagonists for antinociception in inflammatory pain in rats. Front Mol Neurosci. 2017;10(242):3.
   PubMedGoogle Scholar
• Hansen TV, Vik A, Serhan CN, et al. The protectin family of specialized pro-resolving mediators: potent immunoresolvents enabling innovative approaches to target obesity and diabetes. Front Pharmacol. 2019;9:1582.
   PubMed Web of Science ®Google Scholar
• Chiang N, Libreros S, Norris PC, et al. Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions. J Clin Invest. 2019;129(12):5294–5311.
   PubMed Web of Science ®Google Scholar
• Albuquerque-Souza E, Schulte F, Chen T, et al. Maresin-1 and resolvin E1 promote regenerative properties of periodontal ligament stem cells under inflammatory conditions. Front Immunol. 2020;11:585530.
   PubMed Web of Science ®Google Scholar
• Hong S, Tian H, Lu Y, et al. Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes. Am J Physiol Cell Physiol. 2014;307(11):C1058-C1067.
   PubMed Web of Science ®Google Scholar
• Narasimha Das U. Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II. Clin Lipidol. 2013;9(4):465–480.
   Google Scholar
• Das UN. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids. 2013;88(3):201–210.
   PubMed Web of Science ®Google Scholar
• Herrera BS, Hasturk H, Kantarci A, et al. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun. 2014;83(2):792–801.
   PubMed Web of Science ®Google Scholar
• Dinh T, Veves A. Microcirculation of the diabetic foot. Curr Pharm Des. 2005;11(18):2301–2309.
   PubMed Web of Science ®Google Scholar
• Zhang MJ, Sansbury BE, Hellmann J, et al. Resolvin D2 enhances postischemic revascularization while resolving inflammation. Circulation. 2016;134(9):666–680.
   PubMed Web of Science ®Google Scholar
• Menon R, Krzyszczyk P, Berthiaume F, et al. Pro-resolution potency of resolvins D1, D2 and E1 on neutrophil migration and in dermal wound healing. Nano LIFE. 2017;7(1):1750002.
   PubMed Web of Science ®Google Scholar
• Felemban B. Impact of resolvin D1 on RAGE and NF-kB gene expression in human monocytes. Boston Univ. 2013:1–62.
   Google Scholar
• Liua,b T, Xianga A, Peng T, et al. HMGB1–C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proc Nat Acad Sci. 2019;116(46):23254–23263. .
   PubMed Web of Science ®Google Scholar
• Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106(8):1319–1331.
   PubMed Web of Science ®Google Scholar
• Mitchell S, Thomas G, Harvey K, et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol. 2002;13(10):2497–2507.
   PubMed Web of Science ®Google Scholar
• Quiros M, Feier D, Birkl D, et al. Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing. Proc Nat Acad Sci. 2020;117(17):9477–9482.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hu X, Qi X, et al. Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice. Mol Vis. 2018;24:274–285.
   PubMed Web of Science ®Google Scholar
• Pham TL, Kakazu AH, He J, et al. Novel RvD6 stereoisomer induces corneal nerve regeneration and wound healing post-injury by modulating trigeminal transcriptomic signature. Sci Rep. 2020;10(1):4582.
   PubMed Web of Science ®Google Scholar
• Bohr S, Patel SJ, Sarin D, et al. Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen. 2013;21(1):35–43.
   PubMed Web of Science ®Google Scholar
• Hellmann J, Sansbury BE, Wong B, et al. Biosynthesis of D-series resolvins in skin provides insights into their role in tissue repair. J Invest Dermatol. 2018;138(9):2051–2060.
   PubMed Web of Science ®Google Scholar
• Abdolmaleki F, Kovanen PT, Mardani R, et al. Resolvins: emerging players in autoimmune and inflammatory diseases. Clin Rev Allergy Immunol. 2020;58(1):82–91.
   PubMed Web of Science ®Google Scholar